abstract |
(57) [Summary]nThe present invention relates to the use of metronidazole, more preferably a mixture of metronidazole and clindamycin, as an active ingredient for the manufacture of a pharmaceutical composition, in particular a dermatological composition, for anti-inflammatory treatment by a topical route. About. |